Furthermore, combination therapy with 673A and the DSB repair pathway inhibitors, AZD1390 (ATM) and AZD6738 (ATR), resulted in a synergistic killing ovarian cancer cell lines. This evidence concerns the gene ATM and ovarian cancer.